SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : MCAR
MCAR 0.0650-36.3%Jan 31 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: john adriaan kolenberg who wrote (27)4/29/1997 5:16:00 PM
From: Michael Derr   of 467
 
To All,

Hope this pans out. Could give a good boost to the company.

Monday April 28 11:39 AM EDT

Company Press Release

Source: MedCare Technologies Inc.

National Clinical Training Center to be Established for The MedCare
Program in Naperville, IL

Physicians Show Strong Interest in The MedCare Program; Existing MedCare Program Centers
Receive Praise From Patients

LISLE, Ill., April 28 /PRNewswire/ -- MedCare Technologies, Inc. (Nasdaq:MCAR - news) today announced plans to
expand its corporate offices with a new national clinical teaching facility to be located in Naperville, IL. This new center has
been designed specifically to ensure the integrity of The MedCare Program by maintaining consistently high standards during
the recruitment, training and on-going teaching of MedCare's nursing and clinical staff. In addition, this facility will allow for the
national expansion of The MedCare Program by being able to efficiently train greater numbers of staff. ``The timing of our new
teaching facility could not be better,'' said Valerie Boeldt-Umbright, Director of Clinical Services for MedCare Technologies.
``Over the last several months we have received a large volume of letters and calls from physicians all over the country, eager
to offer The MedCare Program to their patents. Without this new facility, we would have a difficult time in satisfying the
demand. I believe this interest from the medical community is a direct result of the tremendous success that we have enjoyed
with our currently established operations. Now that we're discharging some of our earlier patents, its such a pleasure to receive
sincere appreciation from individuals who, without our program, would have otherwise had to contend with surgery, drugs or
continue to use absorbent products to deal with their incontinence.''

Urinary Incontinence is a $16 Billion Market and Affects Almost Half of
All Women
Numerous studies have been completed to determine the prevalence of

urinary incontinence in the general population. The results of one study
completed at Emory University in Atlanta, GA, concluded that the prevalence of
UI was 43.6% among women and 20.9% among men. In another study of 3,638
patients over age 20, 1908 women and 922 men completed an anonymous
questionnaire. A reported 43% of women and 11% of men had current UI. Almost
75% of these patents had not informed a health professional, but more than a
third of these said they would see a physician if treatment were available.
Affecting some 25 million Americans, UI is a $16 billion market and accounts
for almost half of all nursing home admissions. Despite being one of the most
prevalent medical conditions in health care today, with almost half of all
women being affected at some point, UI remains a vastly under-serviced and
over-looked market place.

The MedCare Program Does Not Require FDA Approval and is Risk Free

MedCare Technologies has developed a cost effective, non-drug, non- surgical and non-invasive system for the care and
treatment of patients suffering from urinary incontinence. MedCare's treatment protocol does not require FDA approval, is
covered by most health insurance plans and results in the reduction or complete elimination of 70% to 100% of the most
commonly found urinary incontinence symptoms. Unlike traditional treatment options, which are costly, often unsuccessful or
inadequate, MedCare's proprietary treatment program is completely risk free and has a three year history with a proven
success rate in excess of 85%. MedCare Technologies offers a multi- modality, program based on behavioral techniques and
neuromuscular electromyography biofeedback. The MedCare Program is designed to mobilize and strengthen various
sensory-response systems and is based on operant conditioning strategies whereby specific physiological responses are
progressively shaped, strengthened and coordinated.

SOURCE: MedCare Technologies Inc.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext